Resources

We are indebted to the International Doctors for Healthier Drug Policies for our Resources. We will be adding to them over time.

Monitoring hepatitis C treatment uptake in Australia

Initiations of new treatment for chronic hepatitis C during March to September 2016.

Naloxone and the lethal dose of procrastination & political inaction

In New Zealand it has been difficult to get naloxone on the drug policy agenda let alone into the community, despite the fact that every week someone dies of an opioid overdose.

Opioid epidemic linked to childhood emotional abuse, study shows

Findings suggests new treatment approaches for people who use opioids.

HCV testing remains low among baby boomers, awareness needed

Despite a recommendation from the United States Preventive Services Task Force in 2013 for one-time hepatitis C testing among baby boomers, only 13.8% reported testing in 2015, according to a survey conducted by the American Cancer Society.

Cairns supporting national hepatitis C elimination

Australia is on track to achieve hepatitis C (hep C) elimination within 10 years, having treated more than 30,000 people in 2016 – an estimated 598+ of whom are from Cairns.

The ELPA Study Results

Monitoring European policy responses to viral hepatitis.

The 2016 Hep-CORE Report

Monitoring the implementation of hepatitis B and C policy recommendations in Europe.

From data collection to recommendation - WHO presentation

By Philippa Easterbrook of the Global Hepatitis Programme, HIV Department.

Deborah Small argues why “Policing pregnancy is bad for public health”

In many ways in the United States the treatment of pregnant women has been and continues to be class specific. Low-income women and women of colour have been disproportionately targeted for punitive interventions and are among those with the least access to drug treatment and other health services.

Women, drug policies and incarceration in the Americas

A project by the Washington Office on Latin America, the International Drug Policy Consortium, Dejusticia, and the OAS Inter-American Commission of Women.

The core components of a gender sensitive service for women experiencing multiple disadvantage: A review of the literature

This literature review continues where the Women at Risk report left off, encompassing the same areas of disadvantage faced by women: Contact with the criminal justice system, homelessness, involvement in prostitution or sexual exploitation, serious problems with drug and/or alcohol.

Do no harm - Health, human rights and people who use drugs

Evidence supports the need for a shift in the global approach to drug use. In this report, Do no harm: health, human rights and people who use drugs, UNAIDS shows what works to reduce the impact of HIV and other harms related to drug use. Countries that have moved away from laws and policies that are harmful to people who use drugs and that have increased investment in harm reduction have reduced new HIV infections and improved health outcomes. These policies also deliver broader social benefits, such as lower levels of drug-related crime and reduced pressure on health-care and criminal justice systems.

Opioid substitution treatment in New South Wales, Australia

Written by Dr Alex Wodak AM, Emeritus Consultant, Alcohol and Drug Service, St Vincent's Hospital, Sydney. President, Australian Drug Law Reform Foundation. Director, Australia21

What’s life like for women who use drugs in Indonesia? It’s time we asked them

Women who inject drugs in Indonesia suffer the social repercussions of drug use and dependence differently than men, often with worse outcomes.

Are we in denial about women and addiction?

Ignoring half the world’s population takes concerted effort or at least some level of collusion.

Cambodia joins in the crackdown on drug use

Written by Vic Salas, MD, MPH, Independent Consultant, Phnom Penh, Cambodia/Manila, Philippines.

Reproductive planning for women who use drugs

Women who use drugs have high-risk pregnancies with increased mortality and morbidity among mothers and babies. Adverse outcomes include increased rates of prematurity, low birth weight and intrauterine growth restriction.

The rights and dignity of all pregnant women must be constantly upheld

Every time we divide pregnant women into good ones and bad ones, we become less likely to win our struggle for reproductive justice. The rights and dignity of all pregnant women must be constantly upheld.

INCB Annual Report 2016

INCB report calls for drug policies that take women into account, as countries register disproportionate rise in overdoses among females.

Taking stock: where does Europe stand in the elimination of hepatitis B and C?

In 2016, a regional action plan for Europe that aims to contribute to the implementation of the global viral hepatitis elimination strategy was developed by the WHO Regional Office for Europe. This article looks at how Europe is doing according to these the ten indicators and targets.

The Liberator: Susan Burton on the War on Drugs, black motherhood and freedom

In 1981, Susan Burton’s 5-year-old son, her baby, ran into the street outside their home in South Los Angeles and was killed when a Los Angeles police officer struck him with his car...................... And he kept going.

Centre being considered for babies born addicted to drugs

With the help of Bob Hansen, recently appointed director of addiction services at Marshall University Joan C. Edwards School of Medicine and Marshall Health, a new community group is looking to establish a comprehensive program for babies born addicted to drugs.

Kassandra Frederique, Drug Policy Alliance’s Black History Month series visionary, talks owning our narratives

One cannot discuss black history in its entirety without discussing the war on drugs and dismantling that war will shape our future.

Fatal opioid poisoning: a counterfactual model to estimate the preventative effect of treatment for opioid use disorder in England

First robust analysis estimates that between 2008 and 2011, 880 opioid related "overdose" deaths were prevented each year by addiction treatment in England, reducing total deaths by over 40%.

Women who use drugs need good information and responsive care during pregnancy

Rachel, like all women who use drugs need good information and responsive care during pregnancy. And everyone working together with the further parents in the driving seat.

The Scholar: Samuel K. Roberts Jr. on drug policy, radical recovery and ‘capital flight’

Roberts’ focus on harm reduction for people of colour encompasses much more than ensuring individual safety; rather, it is about dismantling systems that are unsafe for black people in the United States of America.

Women’s voices — experiences and perceptions of women facing drug problems

Epidemiological studies routinely collect quantitative data on gender differences in drug use, but far less is published on the qualitative aspects of women who use drugs. This review, although published in 2009, provide glimpses into the experiences and perceptions of women facing drug issues that statistics alone cannot provide.

Better treatment for ageing people who use drugs: Survey in Europe

Correlation Network are wanting to find examples of good practice in the care of Older people who use drugs. This is for their BeTrAD Project (Better treatment for ageing drug users). By filling in this questionnaire you will help us to get an overview about current services targeting ageing people who use drugs in Europe and collect examples of good practice. Hence develop tailored services for this group.The survey is in the form of a word document. Please email when completed to: mhudepohl@correlation-net.org

Women and gender in the drug war

The criminalization of pregnant women is not only an affront to women’s rights; it puts both mother and fetus at greater risk by erecting barriers to drug treatment and prenatal care.

Towards ‘‘evidence-making intervention’’ approaches in the social science of implementation science: The making of methadone in East Africa

In this commentary, the authors take the recent introduction of methadone treatment in response to emerging problems of HIV linked to heroin addiction in Kenya as a case for reflecting on the social science of implementation science.